178 related articles for article (PubMed ID: 15943222)
1. Longitudinal assessment of the dose consistency of botulinum toxin type A (BOTOX) for cervical dystonia.
Brashear A; Hogan P; Wooten-Watts M; Marchetti A; Magar R; Martin J
Adv Ther; 2005; 22(1):49-55. PubMed ID: 15943222
[TBL] [Abstract][Full Text] [Related]
2. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
[TBL] [Abstract][Full Text] [Related]
3. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
4. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
Samotus O; Lee J; Jog M
J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.
Ferreira JJ; Colosimo C; Bhidayasiri R; Marti MJ; Maisonobe P; Om S
Parkinsonism Relat Disord; 2015 Feb; 21(2):111-5. PubMed ID: 25499753
[TBL] [Abstract][Full Text] [Related]
6. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
8. Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study.
Ruiz PJ; Castrillo JC; Burguera JA; Campos V; Castro A; Cancho E; Chacón J; Vara JH; del Val JL; Garcia EL; Miquel F; Sanz P; Vela L
J Neurol; 2011 Jun; 258(6):1055-7. PubMed ID: 21197540
[TBL] [Abstract][Full Text] [Related]
9. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
[TBL] [Abstract][Full Text] [Related]
10. New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia.
Dressler D; Adib Saberi F
J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):108-9. PubMed ID: 17172580
[No Abstract] [Full Text] [Related]
11. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia.
Naumann M; Yakovleff A; Durif F;
J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia.
Kazerooni R; Broadhead C
Am J Health Syst Pharm; 2015 Feb; 72(4):301-7. PubMed ID: 25631837
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study.
Marchetti A; Magar R; Findley L; Larsen JP; Pirtosek Z; Růzicka E; Jech R; Sławek J; Ahmed F
Mov Disord; 2005 Aug; 20(8):937-44. PubMed ID: 15810022
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
Marsili L; Bologna M; Jankovic J; Colosimo C
Expert Opin Drug Saf; 2021 Jun; 20(6):695-705. PubMed ID: 33831328
[No Abstract] [Full Text] [Related]
16. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
Ranoux D; Gury C; Fondarai J; Mas JL; Zuber M
J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):459-62. PubMed ID: 11909903
[TBL] [Abstract][Full Text] [Related]
17. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.
Schramm A; Bäumer T; Fietzek U; Heitmann S; Walter U; Jost WH
J Neural Transm (Vienna); 2015 Oct; 122(10):1457-63. PubMed ID: 25547861
[TBL] [Abstract][Full Text] [Related]
18. Effective botulinum toxin injection guide for treatment of cervical dystonia.
Yi KH; Choi YJ; Cong L; Lee KL; Hu KS; Kim HJ
Clin Anat; 2020 Mar; 33(2):192-198. PubMed ID: 31301235
[TBL] [Abstract][Full Text] [Related]
19. Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?
Duarte GS; Rodrigues FB; Ferreira JJ; Costa J
Parkinsonism Relat Disord; 2018 Nov; 56():16-19. PubMed ID: 29910156
[TBL] [Abstract][Full Text] [Related]
20. The effect of total cumulative dose, number of treatment cycles, interval between injections, and length of treatment on the frequency of occurrence of antibodies to botulinum toxin type A in the treatment of muscle spasticity.
Bakheit AM; Liptrot A; Newton R; Pickett AM
Int J Rehabil Res; 2012 Mar; 35(1):36-9. PubMed ID: 22108625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
